CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Low-Dose Naltrexone for Chronic Non-Cancer Pain: Clinical Effectiveness

Last updated: June 7, 2017
Project Number: RB1102-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report


  1. What is the clinical effectiveness of low-dose naltrexone for the treatment of adults with chronic non-cancer pain?

Key Message

One randomized controlled trial and one non-randomized study were identified regarding low-dose naltrexone for chronic, non-cancer pain.